Predictions
ShockWave Medical Inc
Start price
Target price
Perf. (%)
€159.00
16.06.21
16.06.21
€225.00
16.06.22
16.06.22
-5.66%
16.06.22
16.06.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€46.95
16.06.21
16.06.21
€75.00
16.06.22
16.06.22
2.24%
28.06.21
28.06.21
Fair valuation
Good rating
Normal challenges to pay loans and raise capital
Leading role in innovation
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€488.40
15.06.21
15.06.21
-
15.06.22
15.06.22
-27.06%
21.05.22
21.05.22
EBIT growth >5% per year expected
Very low/no dividend yield expected
Novartis AG ADR
Start price
Target price
Perf. (%)
€77.60
15.06.21
15.06.21
-
15.06.24
15.06.24
19.07%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Cocrystal Pharma Inc.
Start price
Target price
Perf. (%)
€13.20
14.06.21
14.06.21
€24.00
14.06.22
14.06.22
0.00%
26.06.21
26.06.21
Could be worthwhile Investment >10% per year
Good culture
Little innovation
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€19.30
14.06.21
14.06.21
€22.00
14.06.22
14.06.22
6.74%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
CytRx Corp.
Start price
Target price
Perf. (%)
€2.50
13.06.21
13.06.21
-
13.06.22
13.06.22
-66.00%
27.06.21
27.06.21
Risky Investment
CareCloud Inc.
Start price
Target price
Perf. (%)
€7.30
12.06.21
12.06.21
€8.50
12.06.22
12.06.22
-6.16%
10.07.21
10.07.21
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
CytRx Corp.
Start price
Target price
Perf. (%)
€2.50
12.06.21
12.06.21
-
12.06.22
12.06.22
-95.75%
13.06.22
13.06.22
Could be worthwhile Investment >10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€10.12
12.06.21
12.06.21
€25.00
12.06.22
12.06.22
-70.64%
13.06.22
13.06.22
Could be very worthwhile Investment >20% year
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€18.77
11.06.21
11.06.21
€23.20
11.06.22
11.06.22
-14.32%
24.06.21
24.06.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Galapagos N.V.
Start price
Target price
Perf. (%)
€65.08
09.06.21
09.06.21
€70.00
09.06.22
09.06.22
-30.73%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year
Invitae Corp
Start price
Target price
Perf. (%)
€25.10
09.06.21
09.06.21
€30.00
09.06.22
09.06.22
-89.88%
10.06.22
10.06.22
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€320.85
08.06.21
08.06.21
€330.00
08.06.22
08.06.22
-41.88%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Diasorin SpA
Start price
Target price
Perf. (%)
€142.25
06.06.21
06.06.21
-
06.06.22
06.06.22
-15.04%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
